Sort
21,281 grants matching “influenza”
A Universal Flu Vaccine Based on Conformationally Locked Soluble Headless HA
$224,905Mark Yondola · Avatar Medical, Llc · R43 · FY2015 · AI
Genome Based Influenza Vaccine Strain Selection using Machine Learning
$224,899Xiufeng Henry Wan · Mississippi State University · R01 · FY2019 · AI
Nebulized 'muco-trapping' antibodies for treating respiratory syncytial virus (RSV) infections
$224,893Richard A Cone · Mucommune, Llc · R43 · FY2018 · AI
DEVELOPMENT OF SIRNA NANOJACKETS FOR INFLUENZA TREATMENT
$224,881Mylisa Parette · Keystone Nano, Inc. · N43 · FY2015 · AI
An Affinity Column for Influenza Virus Vaccine Manufacturing
$224,784Xing-Xiang Li · Cellex, Inc. · R43 · FY2007 · AI
Interdisciplinary Training in Virology and Gene Therapy
$224,709Ren Sun · University Of California Los Angeles · T32 · FY2013 · AI
Evaluating Synthetic Biology Produced Triterpene Oils in Adjuvant Formulations
$224,703Joe Chappell · Enepret, Inc. · R41 · FY2018 · AI
Core B Clinical Core
$224,703Tara F Carr · University Of Arizona · U19 · FY2024 · AI
Task Order 2: The Interventional Agent Development Services Program
$224,703Jon Carl Mirsalis · Sri International · N01 · FY2015 · AI
Core B Clinical Core
$224,701Tara F Carr · University Of Arizona · U19 · FY2025 · AI
Shape RNA Structure Analysis for Drug Discovery and Translational Research
$224,700Katherine Deigan Warner · Ribometrix, Llc · R43 · FY2016 · GM
SHAPE RNA Bioinformatics for Therapeutics and Translational Research
$224,636Kevin M Weeks · Ribometrix, Llc · R41 · FY2016 · GM
Competition Among Bacterial Resiratory Pathogens
$224,599University Of Pennsylvania · R21 · FY2003 · AI
Human rhinovirus infection and susceptibility to SARS-CoV-2 infection and symptomatic disease
$224,548Leigh Meredith Howard · Vanderbilt University Medical Center · R21 · FY2024 · AI
INTRODUCING THE USE OF SEASONAL INFLUENZA VACCINE IN PUBLIC HEALTH
$224,488Julius Lutwaama · Uganda Virus Research Institute · U51 · FY2015 · IP
Effectiveness of Hospital-Based Program for Vaccination of Birth Mothers and Hous
$224,474Sylvia H Yeh · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · U01 · FY2009 · IP
Effectiveness of Hospital-Based Program for Vaccination of Birth Mothers and Hous
$224,474Sylvia H Yeh · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · U01 · FY2008 · IP
Integrated, Modular Equipment for Large-scale and Small-scale Peptide Synthesis
$224,422Alan J Waring · University Of California Los Angeles · S10 · FY2008 · RR
Optimizing functional synergies between local and systemic memory CD4 T cell responses to influenza
$224,404Karl Kai McKinstry · University Of Central Florida · R21 · FY2021 · AI
Lnc-PINK regulation of innate immunity in lung epithelial cells
$224,400Lin Liu · Oklahoma State University Stillwater · R21 · FY2021 · AI
Novel Anti-Viral Formulation to Prevent Rhinovirus and Influenza
$224,399Nazlie Latefi · Applied Biological Laboratories, Inc. · R43 · FY2018 · IP
STRUCTURE/FUNCTION OF HEXAPEPTIDE ACYLTRANSFERASE
$224,383Yeshiva University · R01 · FY2000 · AI
Cell-based assay directly monitoring viral polymerase activity for drug discovery.
$224,323Ryan O'Hanlon · Lucerna, Inc. · R43 · FY2020 · AI
Simulations of Proton Translocation in Biomolecules
$224,250University Of Utah · R01 · FY2005 · GM
Deep Sequencing for the Detection of Viral Sequences in Primary Progressive Multi
$224,250John D Kriesel · University Of Utah · R21 · FY2011 · NS